BridgeBio Pharma
BBIO
$50.27
Share price
-3.54%
Change (1 day)
20.10%
Change (1 year)
Categories
BridgeBio Pharma (BBIO) Fails to deliver data
Key failure to deliver metrics for BridgeBio Pharma :
- Last SEC data release: 2025-03-14
- Last 15 days FTD volume: C$0.13 B
- Last 3 months FTD volume: C$0.14 B
- Last year FTD volume: C$0.14 B
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for BridgeBio Pharma (BBIO) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for BridgeBio Pharma (BBIO) - since 2019
Volume in USD (price x number of shares), data since 2019BridgeBio Pharma (BBIO) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2025 | C$0.14 B | 211.33% |
| 2024 | C$46.94 M | 65.36% |
| 2023 | C$28.38 M | 9.5% |
| 2022 | C$25.92 M | -50.08% |
| 2021 | C$51.94 M | -55.92% |
| 2020 | C$0.11 B | 435.85% |
| 2019 | C$21.99 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3 months) | FTD volume (1 year) | Country |
|---|---|---|---|
 | C$0.06 M | C$0.41 M | 🇺🇸 USA |
 | C$3.94 M | C$53.85 M | 🇺🇸 USA |